EGF and hepatocellular carcinoma: With EGF treatment, NIH-3T3 cells harboring EGFR WT, T790M, L858R, and all seven HCC-derived EGFR mutants displayed increased levels of pEGFR at Y869 and Y1092, as compared with their levels without EGF (Fig. 2).